By Stephen Beech

Peanut patch treatment helps toddlers safely build tolerance to the potentially deadly allergy, reveals new research.

More than 70% could tolerate three or four peanut kernels after a three-year course of treatment, say American scientists.

The findings offer encouraging news for parents of around one in 50 young children born with potentially deadly peanut allergies .

The long-term study found that a peanut patch treatment – called epicutaneous immunotherapy, or EPIT – continued to help toddlers safely build tolerance to peanuts over three years.

The treatment, known as the Viaskin Peanut Patch , delivers small amounts of peanut protein through the skin.

The goal is to train the immune system to tolerate peanut exposure and reduce the risk of severe allergic rea

See Full Page